Get notified when MANE files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: MANE Veradermics, Inc 424B3

Veradermics (MANE) registers 17.1M shares for resale by existing investors; company receives no proceeds

Filed August 14, 2026 · ~2 min read

Key Changes

  • high

    This is a resale registration (424B3) for 16,772,058 common shares plus 300,000 shares underlying pre-funded warrants. The company receives no proceeds from these sales; all proceeds go to selling stockholders.

    The Offering verify on EDGAR →
  • high

    The registered shares represent 40.6% of outstanding stock as of August 6, 2026. Four major venture investors are registering to sell their entire holdings: Longitude Capital (4.7M shares), Montanova (4.5M shares), SR One (2.4M shares), and J.W. Childs (2.2M shares).

    Selling Stockholders verify on EDGAR →
  • medium

    CEO Reid Waldman is registering 234,908 shares for sale, and President Timothy Durso is registering 234,907 shares. Four board members are affiliated with the four largest selling stockholders.

    Selling Stockholders verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (PURR 10-K) is open in full — no account needed.

Partner

Trade MANE commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Aug 17, 2026 · How we verify